A Study to Evaluate the Effect of VX-548 on the QT/QTc Interval in Healthy Participants
Clinical trial NCT05818852 · COMPLETED
Trial details
- NCT number
- NCT05818852
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-12
- Primary completion
- 2023-06-12
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.